- Report
- January 2023
- 119 Pages
Global
From €3965EUR$4,500USD£3,416GBP
- Report
- September 2022
- 110 Pages
Global
From €3965EUR$4,500USD£3,416GBP
- Report
- October 2021
- 102 Pages
Global
From €3965EUR$4,500USD£3,416GBP
- Report
- October 2021
- 110 Pages
Global
From €3965EUR$4,500USD£3,416GBP
- Report
- April 2025
- 85 Pages
Saudi Arabia
From €2621EUR$2,975USD£2,259GBP
€3084EUR$3,500USD£2,657GBP
- Report
- February 2025
- 85 Pages
India
From €2621EUR$2,975USD£2,259GBP
€3084EUR$3,500USD£2,657GBP
From €2621EUR$2,975USD£2,259GBP
€3084EUR$3,500USD£2,657GBP
From €2621EUR$2,975USD£2,259GBP
€3084EUR$3,500USD£2,657GBP
- Report
- June 2024
- 182 Pages
Global
From €3370EUR$3,825USD£2,904GBP
€3965EUR$4,500USD£3,416GBP
- Report
- May 2024
- 182 Pages
Global
From €3370EUR$3,825USD£2,904GBP
€3965EUR$4,500USD£3,416GBP
- Report
- May 2024
- 185 Pages
Global
From €3370EUR$3,825USD£2,904GBP
€3965EUR$4,500USD£3,416GBP
- Report
- May 2024
- 186 Pages
Global
From €3370EUR$3,825USD£2,904GBP
€3965EUR$4,500USD£3,416GBP
- Report
- May 2024
- 180 Pages
Global
From €3370EUR$3,825USD£2,904GBP
€3965EUR$4,500USD£3,416GBP
- Report
- May 2024
- 182 Pages
Global
From €3370EUR$3,825USD£2,904GBP
€3965EUR$4,500USD£3,416GBP
- Report
- April 2024
- 88 Pages
France
From €2621EUR$2,975USD£2,259GBP
€3084EUR$3,500USD£2,657GBP
- Report
- April 2024
- 180 Pages
Global
From €3370EUR$3,825USD£2,904GBP
€3965EUR$4,500USD£3,416GBP
- Report
- April 2024
- 180 Pages
Global
From €3370EUR$3,825USD£2,904GBP
€3965EUR$4,500USD£3,416GBP
- Report
- April 2024
- 185 Pages
Global
From €3370EUR$3,825USD£2,904GBP
€3965EUR$4,500USD£3,416GBP
- Report
- February 2024
- 190 Pages
Global
From €3370EUR$3,825USD£2,904GBP
€3965EUR$4,500USD£3,416GBP
- Report
- February 2024
- 174 Pages
Global
From €3370EUR$3,825USD£2,904GBP
€3965EUR$4,500USD£3,416GBP

The biologic market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs. Biologic drugs are made from living organisms, such as proteins, nucleic acids, and cells, and are used to treat a variety of diseases. These drugs are typically more complex and expensive to produce than traditional small-molecule drugs. The biologic market is highly competitive, with many companies vying for market share.
The biologic market is divided into two main segments: therapeutic biologics and biosimilars. Therapeutic biologics are drugs that are developed to treat a specific disease or condition, while biosimilars are drugs that are similar to existing biologic drugs but are not identical.
Some of the major players in the biologic market include Amgen, Biogen, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. These companies are involved in the development, production, and marketing of biologic drugs. Show Less Read more